ReviewCurrent pain and headache reports2026
Current Research on the Diagnosis and Management of Persistent Post-Traumatic Headache.
Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewHeadache is a common symptom in patients with concussion and mild traumatic brain injury. While many patients experience spontaneous resolution of symptoms following injury, a subset develop persistent post-traumatic headache, and evidence-based guidance for the management of this condition remains limited in current clinical practice. RECENT
findingsPersistent post-traumatic headache (PPTH) is likely underrecognized, with evidence suggesting that individuals with a prior history of headache disorders or previous concussion may be at increased risk. Scheduled analgesics in the first 72 hours following injury or utilizing infusions can help reduce symptom severity in the acute period following injury. Pharmacological studies are limited but suggest treating based on the headache phenotype. Anti-CGRP therapies have shown promise in a variety of chronic headache types including PPTH, and non-pharmacological interventions including introduction of early exercise programs, cognitive behavioral therapy, and biofeedback can improve long term patient outcomes. Although the available evidence is limited, current research supports phenotype-guided pharmacologic treatment alongside a multidisciplinary approach incorporating early exercise and cognitive behavioral therapy.
Indexed as
Identifiers
42133249What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.